The Healthtech Podcast

Lissy Hu is the founder and CEO of Careport and came up with the concept while she was getting her MD and MBA at Harvard. She entered and won a Harvard business plan competition in 2012. That same year, she got additional funding, $3.8 million, through the Techstars Boston accelerator program, allowing her to launch CarePort in 2013. The company built out its software, which patients use to find a post-acute provider and hospitals use to track patient outcomes. In 2016, national healthcare IT company Allscripts (NASDAQ: MDRX) acquired CarePort. CarePort’s software is now available both as a standalone product and integrated into Allscript’s platform, which is used by 1,000 hospitals and 20,000 post-acute care facilities. Lissy runs both the CarePort business unit and the larger Allscripts care coordination unit, which were rolled under the CarePort name this year. Subscribe to Healthtech Pigeon 🐦 https://somx.substack.com/p/-006-telehealth-cyberattacks-and Get in touch: www.jamessomauroo.com | www.somx.co.uk

On this week's Sunday session, James drops a clip from the Scrubbed In podcast. He was on that podcast last week discussing personal branding, healthtech and giving his advice to young medics and entrepreneurs. You can catch the full episode at the link below! Scrubbed In with Dr James Somauroo: https://open.spotify.com/episode/24l3QO7zZj6g8pHNnvQcG3?si=7q7fppxbQZSF9xr0AjXIag Read the latest Healthtech Pigeon newsletter 🐦 https://somx.substack.com/p/-006-telehealth-cyberattacks-and Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by Dr Fiona Pathiraja, a consultant radiologist by background and now Managing Partner at Crista Galli Ventures, a brand-new healthtech-specific VC fund investing pan-Europe into companies building the future. James and Fiona discuss her background through clinical medicine, management consulting, and MBA and now founding her own fund. They also discuss the vision for Crista Galli Ventures and Fiona's passion for diversity in both the healthtech and investing spaces. To learn more about Crista Galli Ventures and Dr Fiona Pathiraja: https://www.cristagalli.com | https://www.linkedin.com/in/fionapathiraja/ Subscribe to James' Healthtech Pigeon newsletter 🐦: https://somx.substack.com/p/-005-nhsx-awards-50m-and-theres-a Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week's Sunday Session is all about AI in healthcare. James talks about NHSX's AI Lab and its projects, particularly the The Artificial Intelligence in Health and Care Award, which, excitingly, just issued £50M to 42 AI projects... Get all the updates you need from the Healthtech Pigeon newsletter 🐦 https://somx.substack.com/p/-005-nhsx-awards-50m-and-theres-a Get in touch: www.jamessomauroo.com | www.somx.co.uk

Nicholas Kelly is the chairman of Axela group, which was set up to deliver on the vision of changing the way people view healthcare by supporting the care lifecycle and making care accessible to all. He has over 12 years experience in social care having set up his first domiciliary care agency in 2006, which has grown to be a corner stone of the Axela group. Nicholas has over 10 years leadership experience working in a tech and health environment having previously had senior involvement with Apple and LinkedIn application developments teams. Axela Innovations, launched in 2017, designs systems and products for the health and social care sector. The business has a simple focus of improving the current model of healthcare through the innovative use of technology, particularly employing artificial intelligence (AI), to support, develop, & change how health & social care is delivered. https://www.linkedin.com/in/nickolaskelly | http://axela.co.uk/ Get in touch: www.jamessomauroo.com | www.somx.co.uk Sign up to the Healthtech Pigeon newsletter 🐦 https://somx.substack.com/p/004-healthtech-pigeon-

This week's Sunday session features some tips for entrepreneurs from Joseph Mossel, CEO of Ibex Medial Analytics, info on an upcoming digital health event and info on Healthtech Pigeon 🐦 a newsletter you can sign up to which summarises what James has been reading and listening to in the healthtech world. It's all you need in a 1 minute read! Get discounted tickets for Digital Primary Care 2020: https://hopin.to/events/digital-primary-care-20?code=d20aa6a5-6c8f-439a-8b0f-893e76abe9da Free sign up to Healthtech Pigeon 🐦: https://somx.substack.com/p/004-healthtech-pigeon- Get in touch: www.jamessomauroo.com | www.somx.co.uk

Joseph Mossel is CEO and Co-Founder of Ibex Medical Analytics, a next generation cancer diagnostics startup aiming to reduce diagnostic error and improve patient care. Over his career he served as a software engineer, product manager and in leadership roles in startups, corporates and non-profits, and has taken products from inception to multi-million dollar businesses. He holds a MSc in computer science from Tel Aviv University, and a MSc in environmental science from VU Amsterdam. Ibex Medical Analytics are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realise their vision: Transforming cancer diagnostics with AI and improving patient care. Pathologists are challenged to provide accurate and timely analysis as the number of tests increases every year - Ibex uses artificial intelligence (AI) to develop clinical-grade solutions that help detect cancer as accurately as a human pathologist. Their Galen Platform uses algorithms to analyse images, detect and grade cancer in biopsies and point to other findings with high clinical importance, helping pathologists reduce diagnostic error rates. and enable a more efficient workflow. https://ibex-ai.com/ | https://www.linkedin.com/in/yossimossel/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

For this week's Sunday Session, James chats to Prof Sultan Mahmud, Director of Innovation, Integration and Research at Royal Wolverhampton Hospitals NHS Trust in the UK. From the humblest of beginnings, 'Sul' as he likes to be known rose the ranks through the NHS via jobs in big pharma and is now involved at the coalface of healthtech, helping his Trust bring in technologies like Zesty (you can hear Lloyd Price, cofounder of Zesty a few episodes ago). Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by Graeme Cox, cofounder and CEO of emteq labs. Graeme has led multiple startup companies from initiation to exit, acting both as CEO and CTO with a 25-year track record in AI, software development, client engagement, problem solving and organisational development. His latest company, emteq labs, uses VR, multiple biometrics and machine learning to quantify human emotion. Their integrated system is the most ecologically valid and user-friendly solution on the market and by allowing researchers to harness more accurate data, they enable better research into how humans experience emotions. Listen to the Emotion Lab podcast: https://podcasts.apple.com/gb/podcast/emotion-lab/id1527627404 Get in touch with Graeme or emteq: https://emteqlabs.com/ | https://www.linkedin.com/in/graemercox/ Get in touch with James: www.jamessomauroo.com | www.somx.co.uk

This week's Sunday Session features some bonus content from a conversation between James and Amer Fasihi, cofounder and CEO of healthtech company, Kraydel. The full episode will be out in a couple of weeks, but you'll hear a chat between James and Amer from before they officially started recording the episode. They chat about identity and how it changes as you move careers and companies, the opportunity that comes with first-mover-advantage and entrepreneurs' self confessed affinity to high-risk scenarios. Get in touch: www.jamessomauroo.com | www.somx.co.uk